Antibiotic resistance in Pseudomonas aeruginosa from infections of the ear, nose and throat.
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002228:Carbenicillin; D002701:Chloramphenicol / Q000494:pharmacology; D003091:Colistin / Q000494:pharmacology; D005601:Framycetin / Q000494:pharmacology; D006801:Humans; D008826:Microbial Sensitivity Tests; D009355:Neomycin / Q000494:pharmacology; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy / Q000382:microbiology*; D010118:Oxytetracycline / Q000494:pharmacology; D010403:Penicillin Resistance; D011113:Polymyxins / Q000494:pharmacology; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification; D013307:Streptomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D011113:Polymyxins; D005601:Framycetin; D002701:Chloramphenicol; D000667:Ampicillin; D002228:Carbenicillin; D009355:Neomycin; D010118:Oxytetracycline; D013307:Streptomycin; D003091:Colistin